Currently out of the existing stock ratings of Courtney Breen, 17 are a HOLD (47.22%), 19 are a BUY (52.78%).

Courtney Breen

Work Performance Price Targets & Ratings Chart

Analyst Courtney Breen, currently employed at BERNSTEIN, carries an average stock price target met ratio of 86.36% that have a potential upside of 15.77% achieved within 184 days.

Courtney Breen’s has documented 71 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 14-Jul-2026.

Wall Street Analyst Courtney Breen

Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 1/20/2026. The price target of $335 was fulfilled within 1 day with a profit of $6.28 (1.91%) receiving and performance score of 19.1.

Average potential price target upside

ABBV AbbVie AMGN Amgen BMY Bristol-Myers Squibb Company GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany MRNA Moderna PFE Pfizer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2020

$282

$22.64 (8.73%)

$273

8 days ago
(22-Jul-2026)

14/17 (82.35%)

$28.7 (11.33%)

409

Hold Since 15-Jul-2026

$260

$0.64 (0.25%)

$276

15 days ago
(15-Jul-2026)

19/21 (90.48%)

$15.89 (6.51%)

284

Hold Since 07-Jan-2026

$260

$0.64 (0.25%)

$230

17 days ago
(13-Jul-2026)

2/3 (66.67%)

$12 (4.84%)

89

Buy Since 05-Feb-2024

$300

$40.64 (15.67%)

$258

17 days ago
(13-Jul-2026)

16/17 (94.12%)

$52 (20.97%)

318

Buy Since 25-Feb-2026

$280

$20.64 (7.96%)

$260

20 days ago
(10-Jul-2026)

6/7 (85.71%)

$31.92 (12.87%)

161

Show more analysts

Please expand the browser size to see the chart

Which stock is Courtney Breen is most bullish on?

Potential upside of $188.97 has been obtained for LLY (ELI LILLY AND COMPANY)

What Year was the first public recommendation made by Courtney Breen?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?